Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 study
Cihangir Uyan, Huseyin Arinc, Huseyin Gunduz, Ramazan AkdemirAbant Izzet Baysal University, Izzet Baysal Medical Faculty, Cardiology Department, Bolu, TurkeyAbstract: The study was conducted to evaluate the clinical and angiographic results of the implantation of the paclitaxel-eluting stent Meo:Dru...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-02-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/immediate-and-six-months-clinical-and-angiographic-results-of-intracor-peer-reviewed-article-VHRM |
| _version_ | 1819267660977799168 |
|---|---|
| author | Cihangir Uyan Huseyin Arinc Huseyin Gunduz Ramazan Akdemir |
| author_facet | Cihangir Uyan Huseyin Arinc Huseyin Gunduz Ramazan Akdemir |
| author_sort | Cihangir Uyan |
| collection | DOAJ |
| description | Cihangir Uyan, Huseyin Arinc, Huseyin Gunduz, Ramazan AkdemirAbant Izzet Baysal University, Izzet Baysal Medical Faculty, Cardiology Department, Bolu, TurkeyAbstract: The study was conducted to evaluate the clinical and angiographic results of the implantation of the paclitaxel-eluting stent Meo:DrugStar ST in patients with symptomatic coronary artery disease. The Meo:DrugStar ST stent has a stainless steel stent platform with a homogenous non-biodegradable coating of paclitaxel mixed with a polyether-based biostable, monophase, and hemocompatible coating. Sixty patients with native coronary artery disease were included in the study. The Meo:DrugStar ST stents were implanted in 60 de novo lesions detected in these patients. Immediate and long-term clinical and angiographic follow-up results were evaluated. There was a high proportion of patients with hypertension (55%) according to JNC-VII. Mean stenosis ratio was 78 ± 13 %, mean implanted stent diameter was 3.0 ± 0.4 mm and mean length was 22 ± 5 mm. Restenosis was detected in 4 (10%) of those patients and 11 (27.5%) of 40 patients had insignificant amount of restenosis.The results of this study indicate a potential benefit of the Meo:DrugStar ST stent for the prevention of stent thrombosis and restenosis in these relatively high-risk patients.Keywords: Meo:DrugStar ST stent, paclitaxel drug-eluting stent, coronary artery disease |
| first_indexed | 2024-12-23T21:20:42Z |
| format | Article |
| id | doaj.art-66f6529017e248208f9904062ea7bf07 |
| institution | Directory Open Access Journal |
| issn | 1178-2048 |
| language | English |
| last_indexed | 2024-12-23T21:20:42Z |
| publishDate | 2008-02-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Vascular Health and Risk Management |
| spelling | doaj.art-66f6529017e248208f9904062ea7bf072022-12-21T17:30:46ZengDove Medical PressVascular Health and Risk Management1178-20482008-02-01Volume 41731761582Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 studyCihangir UyanHuseyin ArincHuseyin GunduzRamazan AkdemirCihangir Uyan, Huseyin Arinc, Huseyin Gunduz, Ramazan AkdemirAbant Izzet Baysal University, Izzet Baysal Medical Faculty, Cardiology Department, Bolu, TurkeyAbstract: The study was conducted to evaluate the clinical and angiographic results of the implantation of the paclitaxel-eluting stent Meo:DrugStar ST in patients with symptomatic coronary artery disease. The Meo:DrugStar ST stent has a stainless steel stent platform with a homogenous non-biodegradable coating of paclitaxel mixed with a polyether-based biostable, monophase, and hemocompatible coating. Sixty patients with native coronary artery disease were included in the study. The Meo:DrugStar ST stents were implanted in 60 de novo lesions detected in these patients. Immediate and long-term clinical and angiographic follow-up results were evaluated. There was a high proportion of patients with hypertension (55%) according to JNC-VII. Mean stenosis ratio was 78 ± 13 %, mean implanted stent diameter was 3.0 ± 0.4 mm and mean length was 22 ± 5 mm. Restenosis was detected in 4 (10%) of those patients and 11 (27.5%) of 40 patients had insignificant amount of restenosis.The results of this study indicate a potential benefit of the Meo:DrugStar ST stent for the prevention of stent thrombosis and restenosis in these relatively high-risk patients.Keywords: Meo:DrugStar ST stent, paclitaxel drug-eluting stent, coronary artery diseasehttps://www.dovepress.com/immediate-and-six-months-clinical-and-angiographic-results-of-intracor-peer-reviewed-article-VHRM |
| spellingShingle | Cihangir Uyan Huseyin Arinc Huseyin Gunduz Ramazan Akdemir Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 study Vascular Health and Risk Management |
| title | Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 study |
| title_full | Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 study |
| title_fullStr | Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 study |
| title_full_unstemmed | Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 study |
| title_short | Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 study |
| title_sort | immediate and six months clinical and angiographic results of intracoronary paclitaxel coated stent implantation ndash the meo drugstar 1 study |
| url | https://www.dovepress.com/immediate-and-six-months-clinical-and-angiographic-results-of-intracor-peer-reviewed-article-VHRM |
| work_keys_str_mv | AT cihangiruyan immediateandsixmonthsclinicalandangiographicresultsofintracoronarypaclitaxelcoatedstentimplantationndashthemeodrugstar1study AT huseyinarinc immediateandsixmonthsclinicalandangiographicresultsofintracoronarypaclitaxelcoatedstentimplantationndashthemeodrugstar1study AT huseyingunduz immediateandsixmonthsclinicalandangiographicresultsofintracoronarypaclitaxelcoatedstentimplantationndashthemeodrugstar1study AT ramazanakdemir immediateandsixmonthsclinicalandangiographicresultsofintracoronarypaclitaxelcoatedstentimplantationndashthemeodrugstar1study |